As of 3:59pm ET
| -0.0172 / -4.75%|
The 3 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 1.00, with a high estimate of 2.00 and a low estimate of 0.40. The median estimate represents a +189.86% increase from the last price of 0.35.
The current consensus among 4 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.